LV10426A - Stabili (+)-(1S,2R)-2-[N-hidroksilamino -2- oksoetil)-N-metilamino] karbonil cikloheksan-1-karbonskabes sali panemiens to iegusanai un tos saturosas farmaceitiskas kompozicijas - Google Patents
Stabili (+)-(1S,2R)-2-[N-hidroksilamino -2- oksoetil)-N-metilamino] karbonil cikloheksan-1-karbonskabes sali panemiens to iegusanai un tos saturosas farmaceitiskas kompozicijasInfo
- Publication number
- LV10426A LV10426A LV920358A LV920358A LV10426A LV 10426 A LV10426 A LV 10426A LV 920358 A LV920358 A LV 920358A LV 920358 A LV920358 A LV 920358A LV 10426 A LV10426 A LV 10426A
- Authority
- LV
- Latvia
- Prior art keywords
- cyclohexan
- hydroxyamino
- oxoethyl
- methylamino
- carbonyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI913448A IT1252708B (it) | 1991-12-23 | 1991-12-23 | Sali stabili dell'acido (+)-(1r,2s)-2((n-(2-idrossilammino-2-ossoetil)-n-metilammino)carbonil)cicloesan-1-carbossilico,ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV10426A true LV10426A (lv) | 1995-02-20 |
| LV10426B LV10426B (en) | 1995-08-20 |
Family
ID=11361409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-92-358A LV10426B (en) | 1991-12-23 | 1992-12-23 | STABLE SALTS OF (+)-(1S,2R)-2-{£N-(2-hydroxylamino-2-oxoethyl)-N-methylamino|carbonyl}-cyclohexane-1-carbocyclic acid, process for their preparation and pharmaceutical compositions containing them |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0575572A1 (lv) |
| JP (1) | JPH06506002A (lv) |
| CN (1) | CN1079474A (lv) |
| AU (1) | AU657591B2 (lv) |
| BG (1) | BG98050A (lv) |
| BR (1) | BR9205652A (lv) |
| CA (1) | CA2104372A1 (lv) |
| CZ (1) | CZ379692A3 (lv) |
| EE (1) | EE9400006A (lv) |
| FI (1) | FI933685A (lv) |
| HR (1) | HRP921454A2 (lv) |
| HU (1) | HUT69287A (lv) |
| IT (1) | IT1252708B (lv) |
| LV (1) | LV10426B (lv) |
| MA (1) | MA22749A1 (lv) |
| MX (1) | MX9207543A (lv) |
| NZ (1) | NZ245547A (lv) |
| PL (1) | PL169086B1 (lv) |
| PT (1) | PT101156A (lv) |
| RU (1) | RU2079489C1 (lv) |
| SI (1) | SI9200409A (lv) |
| SK (1) | SK379692A3 (lv) |
| TN (1) | TNSN92117A1 (lv) |
| WO (1) | WO1993013056A1 (lv) |
| YU (1) | YU110892A (lv) |
| ZA (1) | ZA9210004B (lv) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1264860B1 (it) * | 1993-06-21 | 1996-10-17 | Guidotti & C Spa Labor | Derivati di acidi cis- e trans-2(((2-(isdrossiammino)-2-ossoetil)- alchilammino)carbonil)cicloesancarbossilici |
| US5639746A (en) * | 1994-12-29 | 1997-06-17 | The Procter & Gamble Company | Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| FR2817241B1 (fr) | 2000-11-30 | 2003-03-07 | Cebal | Tube aluminium avec embout secable |
| JP2010504969A (ja) * | 2006-09-28 | 2010-02-18 | メルク エンド カムパニー インコーポレーテッド | Ｓａｈａのアミン塩基塩及びその多形 |
| WO2021221984A1 (en) * | 2020-04-27 | 2021-11-04 | Carter-Hoffmann, Llc | Door movement system for cabinet |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1224627B (it) * | 1988-04-12 | 1990-10-04 | Guidotti & C Spa Labor | Ammidi di acidi ciclometilen_1,2_dicarbossilici adattivita' terapeutica, procedimenti per la loro preparazione e composizioni farmaceutiche che le contengono. |
-
1991
- 1991-12-23 IT ITMI913448A patent/IT1252708B/it active IP Right Grant
-
1992
- 1992-12-12 JP JP5511398A patent/JPH06506002A/ja active Pending
- 1992-12-12 EP EP92924726A patent/EP0575572A1/en not_active Withdrawn
- 1992-12-12 RU RU9293052414A patent/RU2079489C1/ru active
- 1992-12-12 HU HU9302389A patent/HUT69287A/hu unknown
- 1992-12-12 AU AU30871/92A patent/AU657591B2/en not_active Ceased
- 1992-12-12 BR BR9205652A patent/BR9205652A/pt not_active Application Discontinuation
- 1992-12-12 WO PCT/EP1992/002903 patent/WO1993013056A1/en not_active Application Discontinuation
- 1992-12-12 CA CA002104372A patent/CA2104372A1/en not_active Abandoned
- 1992-12-21 NZ NZ245547A patent/NZ245547A/en unknown
- 1992-12-21 SK SK3796-92A patent/SK379692A3/sk unknown
- 1992-12-21 CZ CS923796A patent/CZ379692A3/cs unknown
- 1992-12-22 MA MA23040A patent/MA22749A1/fr unknown
- 1992-12-22 SI SI9200409A patent/SI9200409A/sl unknown
- 1992-12-22 HR HR921454A patent/HRP921454A2/hr not_active Application Discontinuation
- 1992-12-23 PL PL92297118A patent/PL169086B1/pl unknown
- 1992-12-23 YU YU110892A patent/YU110892A/sh unknown
- 1992-12-23 TN TNTNSN92117A patent/TNSN92117A1/fr unknown
- 1992-12-23 MX MX9207543A patent/MX9207543A/es unknown
- 1992-12-23 CN CN92113839A patent/CN1079474A/zh active Pending
- 1992-12-23 PT PT101156A patent/PT101156A/pt not_active Application Discontinuation
- 1992-12-23 LV LVP-92-358A patent/LV10426B/lv unknown
- 1992-12-23 ZA ZA9210004A patent/ZA9210004B/xx unknown
-
1993
- 1993-08-18 BG BG98050A patent/BG98050A/bg unknown
- 1993-08-20 FI FI933685A patent/FI933685A/fi not_active Application Discontinuation
-
1994
- 1994-05-23 EE EE9400006A patent/EE9400006A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI9200409A (en) | 1993-09-30 |
| CN1079474A (zh) | 1993-12-15 |
| SK379692A3 (en) | 1995-04-12 |
| YU110892A (sh) | 1996-01-08 |
| HRP921454A2 (en) | 1995-02-28 |
| ZA9210004B (en) | 1993-12-13 |
| WO1993013056A1 (en) | 1993-07-08 |
| MA22749A1 (fr) | 1993-07-01 |
| PL297118A1 (en) | 1993-09-06 |
| ITMI913448A0 (it) | 1991-12-23 |
| PL169086B1 (pl) | 1996-05-31 |
| TNSN92117A1 (fr) | 1993-06-08 |
| JPH06506002A (ja) | 1994-07-07 |
| RU2079489C1 (ru) | 1997-05-20 |
| CA2104372A1 (en) | 1993-06-24 |
| FI933685A0 (fi) | 1993-08-20 |
| EE9400006A (et) | 1995-12-15 |
| LV10426B (en) | 1995-08-20 |
| BR9205652A (pt) | 1994-05-03 |
| AU657591B2 (en) | 1995-03-16 |
| PT101156A (pt) | 1994-06-30 |
| IT1252708B (it) | 1995-06-26 |
| HUT69287A (en) | 1995-09-28 |
| ITMI913448A1 (it) | 1993-06-23 |
| CZ379692A3 (en) | 1993-09-15 |
| BG98050A (bg) | 1994-04-29 |
| NZ245547A (en) | 1995-12-21 |
| FI933685A (fi) | 1993-08-20 |
| EP0575572A1 (en) | 1993-12-29 |
| MX9207543A (es) | 1993-08-01 |
| AU3087192A (en) | 1993-07-28 |
| HU9302389D0 (en) | 1993-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2569949T3 (es) | Formulaciones farmacéuticas que comprenden un péptido complejado con una dicetopiperazina | |
| PL300194A1 (en) | Interferon conjugate, method of obtaining same and pharmaceutical composition containing it | |
| NZ508037A (en) | A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer | |
| DE69212882D1 (de) | Gallensäuresalze enthaltende magenstabile pharmazeutische Zusammensetzung zur oralen Verabreichung | |
| DE69934135D1 (de) | Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen | |
| IL96995A0 (en) | Pharmaceutical compositions containing pimobendan and their preparation | |
| HUP0202501A3 (en) | Pyrimidine-2,4,6-trione metalloproteinase inhibitors, pharmaceutical compositions containing them and their use | |
| ZA96683B (en) | New stabilized galenic formulations comprising an acid labile benzimidazole compound and its preparation | |
| HUP0201291A2 (en) | Di-aryl acid derivatives as ppar receptor ligands and pharmaceutical compositions containing them | |
| PL315679A1 (en) | Liquid compositions for oral administration containing paroxetin resinate | |
| FI971776A (fi) | Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi | |
| HUP0202338A2 (en) | Pharmaceutical composition containing fenofibrate and preparation method | |
| SE0102843L (sv) | Stabiliserad oral farmaceutisk komposition innehållande jodid och jodat och metod | |
| HUP0203716A3 (en) | Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect and pharmaceutical compositions containing them | |
| DE69827357D1 (de) | Menschliches Wachstumshormon enthaltende pharmazeutische Zusammensetzung | |
| DE69226936D1 (de) | Hydroxamatderivate enthaltende pharmazeutische Zusammensetzungen zur Eisenentfernung | |
| YU8701A (sh) | Nova oralna kompozicija | |
| IL128745A0 (en) | Pharmaceutical microspheres containing valproic acid for oral administration | |
| LV10426A (lv) | Stabili (+)-(1S,2R)-2-[N-hidroksilamino -2- oksoetil)-N-metilamino] karbonil cikloheksan-1-karbonskabes sali panemiens to iegusanai un tos saturosas farmaceitiskas kompozicijas | |
| NZ244320A (en) | Acylals of imidazole-5-carboxylic acid, preparation and pharmaceutical compositions thereof | |
| IL114673A (en) | Pharmaceutical compositions containing protein for oral administration | |
| AU2229392A (en) | Method for the preparation of prolonged-release oral pharmaceutical forms containing active substances having a solubility dependent upon the ph value | |
| IT1216797B (it) | Composizioni stabili allo stoccaggio di assorbenti uv | |
| CS240991A3 (en) | Solid forms for oral administration, said forms containing iphosphamide as active component | |
| IL103690A0 (en) | Amorphous(quinolin-2-ylmethoxy)indole derivative,its preparation and pharmaceutical compositions containing it |